Quarterly report · Q3
3937.TEDINET S100SSJU
Period2023-04-01 → 2023-12-31
Filed2024-02-08
StandardJapan GAAP
ConsolidatedYes
Data checks12 of 12 passed
Key figures · 36
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥4.4bn | 2023-04-01 → 2023-12-31 | Cons. | Net sales |
| Revenue | ¥5.2bn | 2022-04-01 → 2023-03-31 | Cons. | Net sales (5-year summary) |
| Revenue | ¥3.9bn | 2022-04-01 → 2022-12-31 | Cons. | Net sales |
| Operating income | ¥773m | 2023-04-01 → 2023-12-31 | Cons. | Operating income |
| Operating income | ¥734m | 2022-04-01 → 2022-12-31 | Cons. | Operating income |
| Ordinary income | ¥717m | 2023-04-01 → 2023-12-31 | Cons. | Ordinary income |
| Ordinary income | ¥1.0bn | 2022-04-01 → 2023-03-31 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥746m | 2022-04-01 → 2022-12-31 | Cons. | Ordinary income |
| Profit before tax | ¥717m | 2023-04-01 → 2023-12-31 | Cons. | Income before income taxes |
| Profit before tax | ¥640m | 2022-04-01 → 2022-12-31 | Cons. | Income before income taxes |
| Net income (owners) | ¥461m | 2023-04-01 → 2023-12-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥574m | 2022-04-01 → 2023-03-31 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥414m | 2022-04-01 → 2022-12-31 | Cons. | Profit loss attributable to owners of parent |
| Net income | ¥461m | 2023-04-01 → 2023-12-31 | Cons. | Profit loss |
| Net income | ¥414m | 2022-04-01 → 2022-12-31 | Cons. | Profit loss |
| Total assets | ¥6.4bn | at 2023-12-31 | Cons. | Assets |
| Total assets | ¥5.8bn | at 2023-03-31 | Cons. | Assets |
| Total assets | ¥5.7bn | at 2022-12-31 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥2.0bn | at 2023-12-31 | Cons. | Liabilities |
| Total liabilities | ¥1.7bn | at 2023-03-31 | Cons. | Liabilities |
| Net assets / equity | ¥4.4bn | at 2023-12-31 | Cons. | Net assets |
| Net assets / equity | ¥4.1bn | at 2023-03-31 | Cons. | Net assets |
| Net assets / equity | ¥4.0bn | at 2022-12-31 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥3.8bn | at 2023-12-31 | Cons. | Cash and deposits |
| Cash and deposits | ¥3.7bn | at 2023-03-31 | Cons. | Cash and deposits |
| EPS (basic) | ¥39.25 | 2023-04-01 → 2023-12-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥13.68 | 2023-10-01 → 2023-12-31d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥48.68 | 2022-04-01 → 2023-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥35.05 | 2022-04-01 → 2022-12-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥6.47 | 2022-10-01 → 2022-12-31d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (diluted) | ¥38.55 | 2023-04-01 → 2023-12-31 | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥47.57 | 2022-04-01 → 2023-03-31 | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥34.2 | 2022-04-01 → 2022-12-31 | Cons. | Diluted earnings per share (5-year summary) |
| Equity ratio | 68.5% | at 2023-12-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 70.6% | at 2023-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 70.1% | at 2022-12-31 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 43
| Segment | Item | Period | Value |
|---|---|---|---|
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue | 2023-04-01 → 2023-12-31 | ¥600,000 |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue external | 2023-04-01 → 2023-12-31 | ¥600,000 |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2023-04-01 → 2023-12-31 | ¥300,000 |
| Reconciling Itemsreconciling | revenue | 2023-04-01 → 2023-12-31 | −¥28m |
| Reconciling Itemsreconciling | revenue intersegment | 2023-04-01 → 2023-12-31 | −¥28m |
| Reconciling Itemsreconciling | segment profit | 2023-04-01 → 2023-12-31 | −¥258m |
| jpcrp040300-q3r_E32408-000Globalreportable segment | revenue | 2023-04-01 → 2023-12-31 | ¥3.2bn |
| jpcrp040300-q3r_E32408-000Globalreportable segment | revenue external | 2023-04-01 → 2023-12-31 | ¥3.2bn |
| jpcrp040300-q3r_E32408-000Globalreportable segment | revenue intersegment | 2023-04-01 → 2023-12-31 | ¥26m |
| jpcrp040300-q3r_E32408-000Globalreportable segment | segment profit | 2023-04-01 → 2023-12-31 | ¥290m |
| jpcrp040300-q3r_E32408-000Medicalreportable segment | revenue | 2023-04-01 → 2023-12-31 | ¥1.2bn |
| jpcrp040300-q3r_E32408-000Medicalreportable segment | revenue external | 2023-04-01 → 2023-12-31 | ¥1.2bn |
| jpcrp040300-q3r_E32408-000Medicalreportable segment | revenue intersegment | 2023-04-01 → 2023-12-31 | ¥3m |
| jpcrp040300-q3r_E32408-000Medicalreportable segment | segment profit | 2023-04-01 → 2023-12-31 | ¥741m |
| —segment total | revenue | 2023-04-01 → 2023-12-31 | ¥4.4bn |
| —segment total | revenue external | 2023-04-01 → 2023-12-31 | ¥4.4bn |
| —segment total | revenue intersegment | 2023-04-01 → 2023-12-31 | ¥28m |
| —segment total | segment profit | 2023-04-01 → 2023-12-31 | ¥1.0bn |
| Total Of Reportable Segments And Otherssegment total | revenue | 2023-04-01 → 2023-12-31 | ¥4.4bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2023-04-01 → 2023-12-31 | ¥4.4bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2023-04-01 → 2023-12-31 | ¥28m |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2023-04-01 → 2023-12-31 | ¥1.0bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue | 2022-04-01 → 2022-12-31 | ¥300,000 |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue external | 2022-04-01 → 2022-12-31 | ¥300,000 |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2022-04-01 → 2022-12-31 | ¥150,000 |
| Reconciling Itemsreconciling | revenue | 2022-04-01 → 2022-12-31 | −¥33m |
| Reconciling Itemsreconciling | revenue intersegment | 2022-04-01 → 2022-12-31 | −¥33m |
| Reconciling Itemsreconciling | segment profit | 2022-04-01 → 2022-12-31 | −¥240m |
| jpcrp040300-q3r_E32408-000Globalreportable segment | revenue | 2022-04-01 → 2022-12-31 | ¥2.8bn |
| jpcrp040300-q3r_E32408-000Globalreportable segment | revenue external | 2022-04-01 → 2022-12-31 | ¥2.8bn |
| jpcrp040300-q3r_E32408-000Globalreportable segment | revenue intersegment | 2022-04-01 → 2022-12-31 | ¥33m |
| jpcrp040300-q3r_E32408-000Globalreportable segment | segment profit | 2022-04-01 → 2022-12-31 | ¥312m |
| jpcrp040300-q3r_E32408-000Medicalreportable segment | revenue | 2022-04-01 → 2022-12-31 | ¥1.1bn |
| jpcrp040300-q3r_E32408-000Medicalreportable segment | revenue external | 2022-04-01 → 2022-12-31 | ¥1.1bn |
| jpcrp040300-q3r_E32408-000Medicalreportable segment | segment profit | 2022-04-01 → 2022-12-31 | ¥662m |
| —segment total | revenue | 2022-04-01 → 2022-12-31 | ¥3.9bn |
| —segment total | revenue external | 2022-04-01 → 2022-12-31 | ¥3.9bn |
| —segment total | revenue intersegment | 2022-04-01 → 2022-12-31 | ¥33m |
| —segment total | segment profit | 2022-04-01 → 2022-12-31 | ¥974m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2022-04-01 → 2022-12-31 | ¥3.9bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2022-04-01 → 2022-12-31 | ¥3.9bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2022-04-01 → 2022-12-31 | ¥33m |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2022-04-01 → 2022-12-31 | ¥974m |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 347
| Item | Context | Value | Unit |
|---|---|---|---|
| Comprehensive income attributable to owners of the parent | Prior1YTDDuration | 397957000 | JPY |
| Comprehensive income attributable to owners of the parent | CurrentYTDDuration | 400653000 | JPY |
| Comprehensive income attributable to non controlling interests | Prior1YTDDuration | － | JPY |
| Comprehensive income attributable to non controlling interests | CurrentYTDDuration | － | JPY |
| Revenues from external customers | Prior1YTDDuration_jpcrp040300-q3r_E32408-000GlobalReportableSegmentMember | 2781329000 | JPY |
| Revenues from external customers | Prior1YTDDuration_jpcrp040300-q3r_E32408-000MedicalReportableSegmentMember | 1129144000 | JPY |
| Revenues from external customers | Prior1YTDDuration_ReportableSegmentsMember | 3910474000 | JPY |
| Revenues from external customers | Prior1YTDDuration_OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember | 300000 | JPY |
| Revenues from external customers | Prior1YTDDuration_TotalOfReportableSegmentsAndOthersMember | 3910774000 | JPY |
| Revenues from external customers | Prior1YTDDuration_ReconcilingItemsMember | － | JPY |
| Revenues from external customers | Prior1YTDDuration | 3910774000 | JPY |
| Transactions with other segments | Prior1YTDDuration_jpcrp040300-q3r_E32408-000GlobalReportableSegmentMember | 32717000 | JPY |
| Transactions with other segments | Prior1YTDDuration_jpcrp040300-q3r_E32408-000MedicalReportableSegmentMember | － | JPY |
| Transactions with other segments | Prior1YTDDuration_ReportableSegmentsMember | 32717000 | JPY |
| Transactions with other segments | Prior1YTDDuration_OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember | － | JPY |
| Transactions with other segments | Prior1YTDDuration_TotalOfReportableSegmentsAndOthersMember | 32717000 | JPY |
| Transactions with other segments | Prior1YTDDuration_ReconcilingItemsMember | -32717000 | JPY |
| Transactions with other segments | Prior1YTDDuration | － | JPY |
| Net sales | Prior1YTDDuration_jpcrp040300-q3r_E32408-000GlobalReportableSegmentMember | 2814047000 | JPY |
| Net sales | Prior1YTDDuration_jpcrp040300-q3r_E32408-000MedicalReportableSegmentMember | 1129144000 | JPY |
| Net sales | Prior1YTDDuration_ReportableSegmentsMember | 3943191000 | JPY |
| Net sales | Prior1YTDDuration_OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember | 300000 | JPY |
| Net sales | Prior1YTDDuration_TotalOfReportableSegmentsAndOthersMember | 3943491000 | JPY |
| Net sales | Prior1YTDDuration_ReconcilingItemsMember | -32717000 | JPY |
| Net sales | Prior1YTDDuration | 3910774000 | JPY |
| Operating income | Prior1YTDDuration_jpcrp040300-q3r_E32408-000GlobalReportableSegmentMember | 312121000 | JPY |
| Operating income | Prior1YTDDuration_jpcrp040300-q3r_E32408-000MedicalReportableSegmentMember | 661751000 | JPY |
| Operating income | Prior1YTDDuration_ReportableSegmentsMember | 973872000 | JPY |
| Operating income | Prior1YTDDuration_OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember | 150000 | JPY |
| Operating income | Prior1YTDDuration_TotalOfReportableSegmentsAndOthersMember | 974022000 | JPY |
| Operating income | Prior1YTDDuration_ReconcilingItemsMember | -240068000 | JPY |
| Operating income | Prior1YTDDuration | 733954000 | JPY |
| Revenues from external customers | CurrentYTDDuration_jpcrp040300-q3r_E32408-000GlobalReportableSegmentMember | 3182546000 | JPY |
| Revenues from external customers | CurrentYTDDuration_jpcrp040300-q3r_E32408-000MedicalReportableSegmentMember | 1214781000 | JPY |
| Revenues from external customers | CurrentYTDDuration_ReportableSegmentsMember | 4397327000 | JPY |
| Revenues from external customers | CurrentYTDDuration_OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember | 600000 | JPY |
| Revenues from external customers | CurrentYTDDuration_TotalOfReportableSegmentsAndOthersMember | 4397927000 | JPY |
| Revenues from external customers | CurrentYTDDuration_ReconcilingItemsMember | － | JPY |
| Revenues from external customers | CurrentYTDDuration | 4397927000 | JPY |
| Transactions with other segments | CurrentYTDDuration_jpcrp040300-q3r_E32408-000GlobalReportableSegmentMember | 25813000 | JPY |
| Transactions with other segments | CurrentYTDDuration_jpcrp040300-q3r_E32408-000MedicalReportableSegmentMember | 2500000 | JPY |
| Transactions with other segments | CurrentYTDDuration_ReportableSegmentsMember | 28313000 | JPY |
| Transactions with other segments | CurrentYTDDuration_OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember | － | JPY |
| Transactions with other segments | CurrentYTDDuration_TotalOfReportableSegmentsAndOthersMember | 28313000 | JPY |
| Transactions with other segments | CurrentYTDDuration_ReconcilingItemsMember | -28313000 | JPY |
| Transactions with other segments | CurrentYTDDuration | － | JPY |
| Net sales | CurrentYTDDuration_jpcrp040300-q3r_E32408-000GlobalReportableSegmentMember | 3208360000 | JPY |
| Net sales | CurrentYTDDuration_jpcrp040300-q3r_E32408-000MedicalReportableSegmentMember | 1217281000 | JPY |
| Net sales | CurrentYTDDuration_ReportableSegmentsMember | 4425641000 | JPY |
| Net sales | CurrentYTDDuration_OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember | 600000 | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 12 of 12 passed
| balance sheet identity | pass rounding |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |